HOME
Products / Services
Partnering
Publications
Request
About Us
ASCO 2019
2019-08-01



IDTitle
e15542
Immune biomarker expression in the tumor microenvironment in Chinese patients with esophageal squamous cell carcinoma was explored
e14068Burden of copy number alterations predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients
e14071A RNA signature predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients
e15612Density of CD8+ and CD68+ lymphocyte cell infiltration is associated with clinic outcome in hepatocellular carcinoma
e15613Association of the ratio of CD8+ and CD163+ lymphocytes with clinical outcome in hepatocellular carcinoma
e13138Validation of a comprehensive cancer genomic profiling assay based on massively parallel DNA sequencing
e14654A comparative analysis of RNA sequencing methods with ribosome RNA depletion for degraded and low-input total RNA from formalin-fixed and paraffin-embedded samples
e15097Genetic characteristics of lung metastasis and liver metastasis from left-sided colorectal cancer with microsatellite stability
e13051A novel computational tool for copy number variation detection in targeted circulating tumor DNA
e13053A new method towards calculating the cancer cell fraction in cell-free DNA
e15649Prediction of hepatocellular carcinoma patient survival using machine learning classification rules
e14219Applying machine learning strategy for microsatellite status detection in plasma sample type
e15650Transcriptional characterization of microenvironment and their prediction role for the prognosis of Hepatocellular carcinoma after surgery
e15730Copy number instability (CNI) combined with CA19-9 as a biomarker for postoperative prognostic prediction of pancreatic cancer
e15555Tumor copy number alteration (CNA) burden as a prognostic factor for overall survival in Chinese gastric cancers
e15552Association of high copy number instability (CNI) score with prognosis in patients with gastric cancer after surgical resection
e15096The mutational landscape of circulating cell-free DNA to identify neoadjuvant chemotherapy response in colorectal cancer patients
e15560The mutational profile analysis of different response to neoadjuvant chemoradiation therapy in local advanced esophageal squamous cell cancer patients
e20625Transcriptional characterization of immune microenvironment and their prediction role for the prognosis of local advanced lung adenocarcinoma
e12582Tracking the tumor evolution of patients with recurrence of ipsilateral breast tumor
e15128The mutational profile analysis of extramural vascular invasion in rectal cancer
e15122The mutational landscape of MSI-H and MSS colorectal cancer
e20043The cross talk between the molecular alterations and tumor immunity in the microenvironment in non-small-cell lung carcinoma
e20588The molecular and immune characteristics, antitumor activity of crizotinib in non-small cell lung cancer (NSCLC) patients with MET exon 14 skipping alterations


TOP